Investment
Features
FeesSafety
Academy
More
Pluang+

Edible Garden AG posts 12.8% Q2 revenue growth but remains unprofitable with EPS of -$18.79.

Company Fundamentals
14 Aug 2026
Danny Green
View Source
Bullish
pluang ai news

Edible Garden AG reported Q2 revenue of $3.60 million, beating analyst estimates and marking a 12.8% increase from last year, driven by strong demand and a new distribution deal with Target. Despite this growth, the company remains unprofitable with an EPS of -$18.79, missing estimates and showing a negative P/E ratio. The company’s controlled environment agriculture method supports scalable growth amid industry consolidation, but profitability challenges persist.

More News

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...

Company Fundamentals
Bullish
22 minutes ago
Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Seaport Global raised the price target for Madison Square Garden Sports Corp. to $473, reflecting a 17.13% potential upside. The company reported strong fiscal Q4 results with earnings per share of $1.19, beating estimates of $0.72, and revenue risin...

Company Fundamentals
Bullish
1 hour ago
Airbus leads aerospace market with strong orders despite production challenges

Airbus leads aerospace market with strong orders despite production challenges

Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...

Market News
Bullish
1 hour ago
PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reported a Q2 2026 GAAP loss per share of $0.87 and a non-GAAP loss of $0.27, beating analyst expectations of a $0.47 loss. Revenue was $33,000, below the $49,000 consensus. Lucid Diagnostics, an investment of PAVmed, generated $1.5 million in...

Company Fundamentals
Bearish
1 hour ago
Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target is expected to report second-quarter earnings of $2.25 per share, a 9.8% increase from last year, with revenues projected at $26.06 billion, up 3.4%. Despite these positive forecasts, the stock has surged 57% year-to-date, leading an analyst t...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App